A detailed history of State Of Wisconsin Investment Board transactions in Eli Lilly & CO stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 490,440 shares of LLY stock, worth $382 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
490,440
Previous 473,736 3.53%
Holding current value
$382 Million
Previous $429 Million 1.3%
% of portfolio
1.15%
Previous 1.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $12.9 Million - $16 Million
16,704 Added 3.53%
490,440 $435 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $592,943 - $743,594
818 Added 0.17%
473,736 $429 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $5.81 Million - $7.77 Million
9,803 Added 2.12%
472,918 $368 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $3.09 Million - $3.64 Million
-5,877 Reduced 1.25%
463,115 $270 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $41.2 Million - $56.7 Million
-94,684 Reduced 16.8%
468,992 $252 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $3.9 Million - $5.21 Million
11,119 Added 2.01%
563,676 $264 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $5.91 Million - $6.94 Million
19,012 Added 3.56%
552,557 $190 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $12.7 Million - $14.8 Million
-39,477 Reduced 6.89%
533,545 $195 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $39.1 Million - $44.5 Million
-131,789 Reduced 18.7%
573,022 $185 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $23.8 Million - $27.9 Million
-85,341 Reduced 10.8%
704,811 $229 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $251,352 - $312,367
1,071 Added 0.14%
790,152 $226 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $15.8 Million - $19.6 Million
-70,118 Reduced 8.16%
789,081 $218 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $37.3 Million - $45.9 Million
-168,159 Reduced 16.37%
859,199 $199 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $22.6 Million - $29.2 Million
-125,167 Reduced 10.86%
1,027,358 $236 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $27.4 Million - $35.5 Million
167,024 Added 16.95%
1,152,525 $215 Million
Q4 2020

Feb 03, 2021

BUY
$130.46 - $172.63 $17.1 Million - $22.7 Million
131,446 Added 15.39%
985,501 $166 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $53.1 Million - $61.5 Million
363,338 Added 74.04%
854,055 $126 Million
Q2 2020

Aug 12, 2020

BUY
$136.42 - $164.18 $4.25 Million - $5.11 Million
31,130 Added 6.77%
490,717 $80.6 Million
Q1 2020

May 06, 2020

SELL
$119.05 - $147.35 $19.7 Million - $24.4 Million
-165,760 Reduced 26.51%
459,587 $63.8 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $6.8 Million - $8.42 Million
-63,561 Reduced 9.23%
625,347 $82.2 Million
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $8.7 Million - $9.46 Million
-81,430 Reduced 10.57%
688,908 $77 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $32.2 Million - $37.6 Million
-290,634 Reduced 27.39%
770,338 $85.3 Million
Q1 2019

May 13, 2019

BUY
$111.31 - $131.02 $12 Million - $14.1 Million
107,695 Added 11.3%
1,060,972 $138 Million
Q4 2018

Feb 11, 2019

SELL
$105.9 - $118.64 $16.4 Million - $18.4 Million
-155,110 Reduced 13.99%
953,277 $110 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $8.2 Million - $10.2 Million
-95,484 Reduced 7.93%
1,108,387 $119 Million
Q2 2018

Aug 03, 2018

BUY
$75.7 - $86.88 $1.17 Million - $1.34 Million
15,428 Added 1.3%
1,203,871 $103 Million
Q1 2018

May 07, 2018

SELL
$74.21 - $87.6 $3.22 Million - $3.8 Million
-43,373 Reduced 3.52%
1,188,443 $92 Million
Q4 2017

Feb 08, 2018

BUY
$81.94 - $87.89 $18.9 Million - $20.3 Million
230,996 Added 23.08%
1,231,816 $104 Million
Q3 2017

Nov 01, 2017

BUY
$77.07 - $85.54 $77.1 Million - $85.6 Million
1,000,820
1,000,820 $85.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.